Total Payments
$2,385
2024 Payments
$458.66
Companies
26
Transactions
94
Medicare Patients
1,371
Medicare Billing
$344,678
Payment Breakdown by Category
Food & Beverage$2,360 (99.0%)
Education$25.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,360 | 92 | 99.0% |
| Education | $25.00 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $368.96 | 8 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $351.65 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $326.62 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $209.47 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $135.25 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.02 | 6 | $0 (2024) |
| Insmed, Inc. | $108.53 | 2 | $0 (2023) |
| AbbVie Inc. | $87.17 | 6 | $0 (2023) |
| Allergan, Inc. | $86.95 | 5 | $0 (2020) |
| Ethicon Inc. | $76.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $458.66 | 20 | GENZYME CORPORATION ($67.87) |
| 2023 | $489.47 | 19 | Actelion Pharmaceuticals US, Inc. ($136.98) |
| 2022 | $83.86 | 5 | Actelion Pharmaceuticals US, Inc. ($32.58) |
| 2021 | $381.15 | 14 | Insmed, Inc. ($85.80) |
| 2020 | $116.07 | 6 | Allergan, Inc. ($86.95) |
| 2019 | $169.69 | 5 | United Therapeutics Corporation ($126.25) |
| 2018 | $164.15 | 9 | Actelion Pharmaceuticals US, Inc. ($43.73) |
| 2017 | $522.00 | 16 | GlaxoSmithKline, LLC. ($216.45) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.94 | General |
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Pulmonology | ||||||
| 10/01/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $24.97 | General |
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/26/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Cardiology | ||||||
| 05/29/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Pulmonology | ||||||
| 02/07/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ANTIBIOTIC | ||||||
| 01/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardio-pulmonary | ||||||
| 12/19/2023 | AbbVie Inc. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/10/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Respiratory | ||||||
| 11/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardio-pulmonary | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/19/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $23.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 328 | 647 | $286,803 | $84,646 |
| 2022 | 7 | 244 | 499 | $215,028 | $64,392 |
| 2021 | 11 | 392 | 668 | $266,195 | $81,515 |
| 2020 | 12 | 407 | 842 | $379,186 | $114,124 |
Total Patients
1,371
Total Services
2,656
Medicare Billing
$344,678
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 137 | 364 | $223,132 | $60,293 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 86 | 148 | $33,448 | $13,557 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 41 | $10,462 | $3,863 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 26 | $9,962 | $3,391 | 34.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 33 | $5,214 | $2,045 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $3,370 | $1,201 | 35.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 15 | $1,215 | $296.55 | 24.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 91 | 261 | $160,121 | $44,677 | 27.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 130 | $29,933 | $10,416 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 43 | $10,520 | $4,027 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $5,104 | $1,844 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,519 | $1,738 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $3,211 | $1,309 | 40.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 11 | 20 | $1,620 | $381.40 | 23.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 127 | 322 | $197,708 | $55,935 | 28.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 90 | 147 | $34,251 | $12,033 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 34 | $10,350 | $4,673 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 43 | $9,788 | $4,051 | 41.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $5,226 | $1,680 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 24 | $3,912 | $1,355 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $2,310 | $984.29 | 42.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 14 | 16 | $1,216 | $353.92 | 29.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 19 | 20 | $580.00 | $163.23 | 28.1% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 17 | 17 | $476.00 | $160.09 | 33.6% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 18 | 18 | $378.00 | $126.54 | 33.5% |
About Dr. Stephen Brierre, MD
Dr. Stephen Brierre, MD is a Pulmonary Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316960362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Brierre, MD has received a total of $2,385 in payments from pharmaceutical and medical device companies, with $458.66 received in 2024. These payments were reported across 94 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,360).
As a Medicare-enrolled provider, Brierre has provided services to 1,371 Medicare beneficiaries, totaling 2,656 services with total Medicare billing of $344,678. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Baton Rouge, LA
- Active Since 07/25/2006
- Last Updated 02/16/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1316960362
Products in Payments
- UPTRAVI (Drug) $307.92
- Adempas (Drug) $209.47
- NUCALA (Biological) $198.20
- ORENITRAM (Drug) $168.95
- AVYCAZ (Drug) $143.71
- Arikayce (Drug) $108.53
- DUPIXENT (Biological) $100.46
- Monarch Platform (Device) $76.11
- BREO (Drug) $71.58
- OFEV (Drug) $59.83
- TYVASO (Drug) $50.04
- Hillrom - Life 2000 Ventilation System (Device) $47.49
- YUPELRI (Drug) $43.85
- OPSUMIT MACITENTAN (Drug) $43.73
- STIOLTO RESPIMAT (Drug) $41.30
- Flexitouch Plus (Device) $38.82
- Prolastin-C Liquid (Biological) $37.43
- ANORO (Drug) $34.23
- DALVANCE (Drug) $30.41
- DUPIXENT DUPILUMAB INJECTION (Biological) $24.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baton Rouge
Robert Hinkle, Md, MD
Pulmonary Disease — Payments: $32,737
Pulmonary Disease $32,737
Dr. Alexander Mulamula, M.d, M.D
Pulmonary Disease — Payments: $9,086
Pulmonary Disease $9,086
Vincent Valentine, Md, MD
Pulmonary Disease — Payments: $6,427
Pulmonary Disease $6,427
Mostafa Aboubakr, Md, MD
Pulmonary Disease — Payments: $4,838
Pulmonary Disease $4,838
Jonathan Richards, Md, MD
Pulmonary Disease — Payments: $2,365
Pulmonary Disease $2,365
Dr. Stuart Lebas, M.d, M.D
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829